A Phase 3, Multi-center, Multinational, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Levofloxacin Inhalation Solution (APT-1026) in Stable Cystic Fibrosis Patients
Resource Type
CF Research News
Authors
Patrick A. Flume
Donald R. VanDevanter
Elizabeth E. Morgan
Michael N. Dudley
Jeffery S. Loutit
Scott C. Bell
Eitan Kerem
Rainald Fischer
Alan R. Smyth
Shawn D. Aaron
Douglas Conrad
David E. Geller
J. Stuart Elborn on behalf of the APT investigators
References
J Cyst Fibros. 2016 Feb 4. pii: S1569-1993(15)00276-3.